Log in to save to my catalogue

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention...

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1461873502

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study

About this item

Full title

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study

Publisher

Kidlington: Elsevier Ltd

Journal title

The Lancet (British edition), 2013-11, Vol.382 (9906), p.1714-1722

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Dual antiplatelet therapy (DAPT) cessation increases the risk of adverse events after percutaneous coronary intervention (PCI). Whether risk changes over time, depends on the underlying reason for DAPT cessation, or both is unknown. We assessed associations between different modes of DAPT cessation and cardiovascular risk after P...

Alternative Titles

Full title

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1461873502

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1461873502

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(13)61720-1

How to access this item